ADmit Therapeutics logo

ADmit Therapeutics jobs and careers

Barcelona, Spain

About ADmit Therapeutics

ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

Founded in 2017 by Marta Barrachina.

Founded
2017
Employees
1 to 10
Total funding
$8M
Headquarters
Barcelona

Leadership

The top of ADmit Therapeutics's org chart, with how many people report into each leader.

MBPhoto of Marta Barrachina

Marta Barrachina

Member Of The Board Of Directors